Search Results - "CURT, G. A"
-
1
Fatigue in cancer
Published in BMJ (30-06-2001)“…Regular bed and waking times should be established, and the patient should perform restful activities before going to bed. 4 Although rest is commonly advised…”
Get full text
Journal Article -
2
Impact of Cancer‐Related Fatigue on the Lives of Patients: New Findings From the Fatigue Coalition
Published in The oncologist (Dayton, Ohio) (01-10-2000)“…Purpose. This survey was designed to confirm the prevalence and duration of fatigue in the cancer population and to assess its physical, mental, social, and…”
Get full text
Journal Article -
3
Polyglutamation of methotrexate: is methotrexate a prodrug?
Published in The Journal of clinical investigation (01-09-1985)Get full text
Journal Article -
4
Phase I/II multicenter study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD4877 in patients with refractory acute myeloid leukemia
Published in Investigational new drugs (01-06-2012)“…Summary Eg5 (kinesin spindle protein) is a microtubule motor protein, essential for centrosome separation during mitosis. This Phase I/II, open-label,…”
Get full text
Journal Article -
5
Terrorism and Cancer
Published in The oncologist (Dayton, Ohio) (01-01-2001)Get full text
Journal Article -
6
2′,3′-Didehydro-3′-deoxythymidine (d4T) in Patients with AIDS or AIDS-Related Complex: A Phase I Trial
Published in The Journal of infectious diseases (01-01-1993)“…2′,3′-didehydro-3′-deoxythymidine (d4T) is a pyrimidine analogue and inhibitor of reverse transcriptase with potent in vitro activity against human…”
Get full text
Journal Article -
7
The pharmacology and clinical use of methotrexate
Published in The New England journal of medicine (03-11-1983)Get more information
Journal Article -
8
-
9
Formation of methotrexate polyglutamates in purified myeloid precursor cells from normal human bone marrow
Published in The Journal of clinical investigation (01-03-1985)“…Immature myeloid precursor cells were preferentially selected from normal human bone marrow by using immune rosette techniques that employed monoclonal…”
Get full text
Journal Article -
10
Effect of calcium channel blockers on human CFU-GM with cytotoxic drugs
Published in Journal of clinical oncology (01-03-1987)“…Calcium channel blockers (CCBs) such as verapamil and nitrendipine are capable of increasing drug sensitivity in resistant murine and human tumor cells. This…”
Get more information
Journal Article -
11
Determinants of the sensitivity of human small-cell lung cancer cell lines to methotrexate
Published in The Journal of clinical investigation (01-10-1985)“…We have characterized the determinants of methotrexate (MTX) responsiveness in eight patient-derived cell lines of small-cell lung cancer (SCLC). Clonogenic…”
Get full text
Journal Article -
12
The Evolving Face of Palliative Care in Cancer Medicine
Published in The oncologist (Dayton, Ohio) (1999)Get full text
Journal Article -
13
Phase I and clinical pharmacology study of intravenous flavone acetic acid (NSC 347512)
Published in Cancer research (Chicago, Ill.) (15-10-1988)“…We have conducted a Phase I and pharmacological study of flavone acetic acid, one of a series of novel flavonoids. The drug was administered i.v. weekly for 4…”
Get full text
Journal Article -
14
CME Online: For the Oncologist from The Oncologist
Published in The oncologist (Dayton, Ohio) (01-12-2001)Get full text
Journal Article -
15
The Basic Immunology of ASCO
Published in The oncologist (Dayton, Ohio) (2000)Get full text
Journal Article -
16
Reversible acute pulmonary edema due to uncontrolled hyperglycemia in diabetic individuals with renal failure
Published in Diabetes care (01-09-1982)“…Reversible acute pulmonary edema due to uncontrolled hyperglycemia in diabetic individuals with renal failure. A Kaldany , G A Curt , N M Estes , L A Weinrauch…”
Get full text
Journal Article -
17
The use of animal models in cancer drug discovery and development
Published in Stem cells (Dayton, Ohio) (01-01-1994)“…The process of searching for new cancer drugs has evolved from rational empiricism using high volume murine screens towards more targeted systems designed to…”
Get more information
Journal Article -
18
Phase II and pharmacokinetic study of aziridinylbenzoquinone [2,5-diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone, diaziquone, NSC 182986] in high-grade gliomas
Published in Cancer research (Chicago, Ill.) (01-12-1983)“…2,5-Diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone (AZQ; Diaziquone, NSC 182986) is a rationally designed antitumor drug possessing sufficient lipid…”
Get full text
Journal Article -
19
Drug resistance in cancer
Published in Cancer treatment reports (01-01-1984)Get more information
Journal Article -
20
A phase I and pharmacokinetic study of dihydro-5-azacytidine (NSC 264880)
Published in Cancer research (Chicago, Ill.) (01-07-1985)“…5,6-Dihydro-5-azacytidine (DHAC; NSC 264880) is an analogue of 5-azacytidine that does not possess the hydrolytically unstable 5,6-imino bond of the parent…”
Get full text
Journal Article